NCT03231137View on ClinicalTrials.gov

Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 16, 2012

Primary Completion Date

March 12, 2017

Study Completion Date

July 10, 2017

Conditions
Alveolar Socket Preservations
Interventions
COMBINATION_PRODUCT

PRGF/ATV

Atorvastatin (ATV) loaded on plasma rich in growth factor (PRGF) Derived Fibrin Scaffold

DRUG

ATV gel

Atorvastatin gel

BIOLOGICAL

PRF

Platelet rich fibrin

BIOLOGICAL

PRGF

plasma rich in growth factor

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03231137 - Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination | Biotech Hunter | Biotech Hunter